CS224990B1 - The substituted 10-/4-/chloralkyl/piperazine/-10,11-dihydrodibenzo/b,f-thiepines and their salts - Google Patents
The substituted 10-/4-/chloralkyl/piperazine/-10,11-dihydrodibenzo/b,f-thiepines and their salts Download PDFInfo
- Publication number
- CS224990B1 CS224990B1 CS604882A CS604882A CS224990B1 CS 224990 B1 CS224990 B1 CS 224990B1 CS 604882 A CS604882 A CS 604882A CS 604882 A CS604882 A CS 604882A CS 224990 B1 CS224990 B1 CS 224990B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- dihydrodibenzo
- salts
- thiepines
- substituted
- chloralkyl
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims description 5
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 125000004965 chloroalkyl group Chemical group 0.000 claims description 2
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 235000005985 organic acids Nutrition 0.000 claims description 2
- 150000003551 thiepines Chemical class 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000007059 acute toxicity Effects 0.000 description 3
- 231100000403 acute toxicity Toxicity 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- CQVKMVQRSNNAGO-UHFFFAOYSA-N 2-[4-formyl-3-methyl-n-(2-methylsulfonyloxyethyl)anilino]ethyl methanesulfonate Chemical compound CC1=CC(N(CCOS(C)(=O)=O)CCOS(C)(=O)=O)=CC=C1C=O CQVKMVQRSNNAGO-UHFFFAOYSA-N 0.000 description 2
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 2
- -1 4- (3-chloropropyl) piperazino Chemical group 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000002903 catalepsic effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000000099 in vitro assay Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000009132 Catalepsy Diseases 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010058667 Oral toxicity Diseases 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 101100073357 Streptomyces halstedii sch2 gene Proteins 0.000 description 1
- 206010047853 Waxy flexibility Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002908 adrenolytic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000418 oral toxicity Toxicity 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Tento vynález se týká 8-substituovaných lG-/4-(chloralkyl)piperazino/-1Q»11-dihydrodibenzo(b,f)thiepinů obecného vzorce I, (I) ve kterém R značí atom chloru nebo methylthioskupinu a n značí 2 nebo 3, a jejich solí s farmaceuticky nezávadnými anorganickými nebo organickými kyselinami.The present invention relates to 8-substituted 1H- [4- (chloroalkyl) piperazino] -1H-11-dihydrodibenzo (b, f) thiepines of formula (I): (I) wherein R is chlorine or methylthio and n is 2 or 3, and salts thereof with pharmaceutically acceptable inorganic or organic acids.
Látky vzorce I a jejich soli jsou nízkokataleptická neuroleptika se značnou centrálně tlumivou a diskoordinační účinností. Jsou to antipsychoticky účinné látky s nízkým výskytem extrapyramidových vedlejších reakcí. Zčásti působí intensivně adrenolyticky a snižují krevní tlak, takže je lze považovat těž za antihypertensiva. V testech in vitro působí inhibičně na celou řadu pathogenních mikroorganismů, takže mají též charakter antimikrobiálních chemotherapeutik. Uvedené účinky byly zjištěny jak v testech in vivo na pokusných zvířatech, tak i v testech in vitro, jak je to dále uvedeno konkrétně.The compounds of formula I and their salts are low-cataleptic neuroleptics with considerable central buffering and discoordinating activity. They are antipsychotically active substances with a low incidence of extrapyramidal side reactions. In part, they act intensively adrenolytically and lower blood pressure, so they can be considered as antihypertensives. In in vitro assays, they inhibit many pathogenic microorganisms, so that they also have the character of antimicrobial chemotherapeutics. These effects have been found both in in vivo tests in experimental animals and in in vitro tests, as follows.
Typickou látkou podle vynálezu je 2-chlor-11-/4-(2-chlorethyl)piperazino/-10,11-dihydrodibenzo(b,f)thiepin (I, R = Cl, n = 2), který byl testován ve formě raethansulfonátu a uvedené dávky jsou přepočty na basi. Akutní toxicita u myší, LD^q «A typical compound of the invention is 2-chloro-11- [4- (2-chloroethyl) piperazino] -10,11-dihydrodibenzo (b, f) thiepine (I, R = Cl, n = 2), which was tested in the form of raethane sulfonate and the doses are calculated on a basis. Acute toxicity in mice, LD ^ q «
115 mg/kg p.o. Diskoordinační působení v testu rotující tyčky,115 mg / kg p.o. Discoordination effect in rotating rod test,
ED^q (střední účinná dávka vyvolávající ataxii u 50 % zvířat v době maxima účinku) je 3,0 mg/kg p.o. Kataleptický účinek,ED 50 (mean effective dose inducing ataxia in 50% of animals at time of maximum effect) is 3.0 mg / kg p.o. Cataleptic effect,
224 990224 990
EDj-θ (střední účinná dávka vyvolávající katalepsii u 50 % krys) je 26 mg/kg p.o. Akutní toxicita při intravenosním podání myším není o mnoho vyšší než toxicita orální, LD^q » 75 mg/kg i.v.EDi-θ (mean effective dose inducing catalepsy in 50% of rats) is 26 mg / kg p.o. The acute toxicity by intravenous administration to mice is not much higher than oral toxicity, LD 50 q 75 mg / kg i.v.
V dávce 15 mg/kg i.v, vyvolává signifikantní poklesy krevního tlaku u normotensních krys. Má význačný účinek adrenolytický ϊ v dávce 0,5 mg/kg i.v. snižuje u krys presorickou odpověd na adrenalin na 50 % kontrolní hodnoty. V koncentracích 12,5 až 50 yug/ml inhibuje růst dále uvedených mikroorganismů v testech in vitro : Streptococcus J^-haemolyticus, Streptococcus faecalis, Staphylococcus pyogenes aureus, Mycobacterium tuberculosis, Saccharomyces pasterianus, Trichophyton mentagrophytes.At a dose of 15 mg / kg i.v, it induces significant decreases in blood pressure in normotensive rats. It has a marked adrenolytic effect at a dose of 0.5 mg / kg i.v. decreases the adrenaline response to 50% of the control value in rats. At concentrations of 12.5 to 50 µg / ml, it inhibits the growth of the following microorganisms in in vitro assays: Streptococcus β-haemolyticus, Streptococcus faecalis, Staphylococcus pyogenes aureus, Mycobacterium tuberculosis, Saccharomyces pasterianus, Trichophyton mentagrophytes.
Další typickou látkou podle vynálezu je 2-methylthio-11/4-(3-chlorpropyl)p ip erazino/-10,11-dihydrodibenzo(b,f)thiep in (I, R » SCH·}, n «= 3), který byl testován ve formě dimethansulfonátu. Její akutní toxicita u myší, LD^q β 190 mg/kg p.o. Diskoordinační působení v testu rotující tyčky u myší, ED^q *Another typical compound of the invention is 2-methylthio-11 / 4- (3-chloropropyl) piperazino / -10,11-dihydrodibenzo (b, f) thiepine (I, R ' SCH '), n ' = 3) , which was tested in the form of dimethanesulfonate. Its acute toxicity in mice, LD ^ q β 190 mg / kg p.o. Discoordination effect in rotating rod test in mice, ED ^ q *
3,9 mg/kg p.o. Kataleptický účinek u krys, ED^q a 23,5 mg/kg p.o. V koncentracích 25 až 50 jug/ml inhibuje růst kultur Mycobacterium tuberculosis a Trichophyton mentagrophytes.3.9 mg / kg p.o. Cataleptic effect in rats, ED50 and 23.5 mg / kg p.o. At concentrations of 25 to 50 µg / ml, it inhibits the growth of Mycobacterium tuberculosis and Trichophyton mentagrophytes cultures.
Látky vzorce I lze získat z příslušných aminoalkcholů obec-The compounds of formula I can be obtained from the corresponding aminoalkcholes in general.
ve kterém Ran značí totéž jako ve vzorci I, působením thionylchloridu, nejlépe v benzenu nebo chloroformu za přítomnosti pyridinu. Výchozí látky vzorce II jsou látky známé (Jílek J.0. a spol., Collect.Czech.Chem.Commun. ^6. 2226, 1971). Látky vzorce I jako base jsou relativně stálé a neutralisací kyselinami poskytují příslušné soli, z nichž zvláště methansulřonáty jsou pro svou výbornou rozpustnost ve vodě výhodnější než base k provádění farmakologických testů i k výrobě lékových forem.in which Ran denotes the same as in formula I by treatment with thionyl chloride, preferably in benzene or chloroform in the presence of pyridine. The starting materials of the formula II are known compounds (Jílek J.0. Et al., Collect.Czech.Chem.Commun. 6, 2226, 1971). The compounds of the formula I as bases are relatively stable and give the corresponding salts by acid neutralization, of which, in particular, the methanesulphonates are advantageous for their excellent water solubility than bases for carrying out pharmacological tests and for producing pharmaceutical forms.
Příklad 1Example 1
224 990224 990
2-Chlor-11-/4-(2-chlorethyl)piperazino/-10,11-dihydrodibenzo(b,f)thiepin (I, R » Cl, n » 2). K roztoku 30,0 g hemihydrátu 2-chlor-11-/4-(2-hydroxyethyl)piperazino/-10,11-dihydrodibenzo(b,f)thiepinu (Jílek J.O. a spol., citováno) ve směsi 250 ml benzenu a 12,5 g pyridinu se za míchání při 10 °C zvolna přikape2-Chloro-11- [4- (2-chloroethyl) piperazino] -10,11-dihydrodibenzo (b, f) thiepine (I, R, Cl, n, 2). To a solution of 30.0 g of 2-chloro-11- [4- (2-hydroxyethyl) piperazino] -10,11-dihydrodibenzo (b, f) thiepine hemihydrate (Jílek JO et al., Cited) in a mixture of 250 ml of benzene and 12.5 g of pyridine are slowly added dropwise with stirring at 10 ° C
16.4 g thionylchloridu. Směs se míchá ještě 2 h při teplotě místnosti, rozloží se 250 ml vody a zalkalisuje 5% hydroxidem sodným. Produkt se extrahuje benzenem, extrakt se promyje vodou a potom se protřepe s přebytkem 3M-HC1. Vyloučený hydroehlorid se odsaje, suspenduje se ve vodné fázi filtrátu, suspense se zalkalisuje 10% roztokem hydroxidu sodného a produkt se znovu extrahuje benzenem. Odpařením extraktu se získá 29,5 g surového produktu, který se rozpustí v 50 ml benzenu a chromatografuje na sloupci16.4 g of thionyl chloride. The mixture was stirred for another 2 h at room temperature, quenched with 250 mL of water and basified with 5% sodium hydroxide. The product was extracted with benzene, the extract was washed with water and then shaken with an excess of 3M-HCl. The precipitated hydrochloride is filtered off with suction, suspended in the aqueous phase of the filtrate, the suspension is made alkaline with 10% sodium hydroxide solution and the product is again extracted with benzene. Evaporation of the extract gave 29.5 g of crude product which was dissolved in 50 ml of benzene and chromatographed on a column
120 g neutrálního kysličníku hlinitého (aktivita II). Elucí benzenem se získá 24,4 g homogenního produktu, který stáním krystaluje, t.t. 105 až 106 °C (cyklohexan). Heutralisací kyselinou maleinovou ve směsi ethanolu a acetonu poskytuje maleinát tající při 151 až 153 °C (ethanol). Heutralisací base kyselinou methansulfonovou ve směsi ethanolu a etheru se získá krystalický monómethansulfonát tající při 168 až 169 °C (ethanol-ether).120 g of neutral alumina (activity II). Elution with benzene gave 24.4 g of a homogeneous product which crystallized on standing, m.p. 105-106 ° C (cyclohexane). Heutralization with maleic acid in a mixture of ethanol and acetone affords the maleate melting at 151-153 ° C (ethanol). Heutralization of the base with methanesulfonic acid in a mixture of ethanol and ether gave a crystalline monomethanesulfonate melting at 168-169 ° C (ethanol-ether).
Příklad 2Example 2
2-Methylthio-11-/4-(3-chlorpropyl)piperazino/-10,11-dihydrodibenzo(b,f)thiepin (I, R » SCH^, n = 3). K roztoku 20 g 2-methylthio-11-/4-(3-hydroxypropyl)piperazino/-10,11-dihydrodibenzo(b,f)thiepinu (Jílek J.O. a spol,, citováno) ve 200 ml chloroformu ge přidá 8 ml pyridinu a potom se za míchání zvolna přikape 24 g thionylchloridu tak, aby teplota nepřekročila 40 až 45 °C. Směs se ponechá při teplotě místnosti přes noc, rozloží se 200 ml 10% roztoku hydroxidu sodného a za vnějšího chlazení ledovou vodou se silně zalkalisuje 35% roztokem hydroxidu sodného. Chloroformová fáze se oddělí a odpaří za sníženého tlaku. Zbytek se rozpustí v 250 ml benzenu, roztok se protřepe s 200 ml 3M-HC1, vyloučený hydroehlorid se odsaje a suspenduje se ve vodě. Suspense se zalkalisuje 15% hydroxidem sodným a base extrahuje benzenem. Extrakt se odpaří a zbytek se chromatografuje na sloupci 500 g neutrálního kysličníku hlinitého (aktivita II). Elucí benzenem se získá2-Methylthio-11- [4- (3-chloropropyl) piperazino] -10,11-dihydrodibenzo (b, f) thiepine (I, R ' SCH2, n = 3). To a solution of 20 g of 2-methylthio-11- [4- (3-hydroxypropyl) piperazino] -10,11-dihydrodibenzo (b, f) thiepine (Jílek JO et al., Cited) in 200 ml of chloroform is added 8 ml of pyridine. and then 24 g of thionyl chloride is slowly added dropwise with stirring so that the temperature does not exceed 40-45 ° C. The mixture is left at room temperature overnight, quenched with 200 ml of 10% sodium hydroxide solution and strongly alkalized with 35% sodium hydroxide solution while cooling with ice water. The chloroform phase was separated and evaporated under reduced pressure. The residue is dissolved in 250 ml of benzene, shaken with 200 ml of 3M-HCl, the precipitated hydrochloride is filtered off with suction and suspended in water. The suspension was basified with 15% sodium hydroxide and the base extracted with benzene. The extract is evaporated and the residue is chromatographed on a column of 500 g of neutral alumina (activity II). Elution with benzene yields
13.5 g (65 %) homogenního olejovitého produktu, který neutrali1 224 990 sací kyselinou maleinovou v ethanolu poskytuje krystalický maleinát, t.t. 162 až 164 °C (vodný ethanol). Neutralisací base kyse«? linou methansulfonovou v ethanolu. se získá dimethansulfonát, který krystaluje z acetonu a v čistém stavu taje při 160 až 163 °C.13.5 g (65%) of homogeneous oily product which neutralize 1224990 suction maleic acid in ethanol, the crystalline maleate, mp 162-164 ° C (aqueous ethanol). Neutralizing base acid «? methanesulfonic acid line in ethanol. dimethane sulfonate is obtained which crystallizes from acetone and melts in the pure state at 160-163 ° C.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS604882A CS224990B1 (en) | 1982-08-17 | 1982-08-17 | The substituted 10-/4-/chloralkyl/piperazine/-10,11-dihydrodibenzo/b,f-thiepines and their salts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS604882A CS224990B1 (en) | 1982-08-17 | 1982-08-17 | The substituted 10-/4-/chloralkyl/piperazine/-10,11-dihydrodibenzo/b,f-thiepines and their salts |
Publications (1)
Publication Number | Publication Date |
---|---|
CS224990B1 true CS224990B1 (en) | 1984-02-13 |
Family
ID=5406647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS604882A CS224990B1 (en) | 1982-08-17 | 1982-08-17 | The substituted 10-/4-/chloralkyl/piperazine/-10,11-dihydrodibenzo/b,f-thiepines and their salts |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS224990B1 (en) |
-
1982
- 1982-08-17 CS CS604882A patent/CS224990B1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68906803T2 (en) | Anxiety and antidepressant tetrahydrobenzothienopyridine derivatives. | |
DD140746A5 (en) | PROCESS FOR THE PRODUCTION OF PROSTAGLAND IN ANTAGONISTS | |
DD158242A5 (en) | METHOD FOR THE PREPARATION OF SUBSTITUTED DIBENZO-OXEPINES | |
CS196893B1 (en) | 3-fluor-10-piperazino-8-substituted 10,11-dihydro-dibenzothiepines | |
EP0003016A1 (en) | Pyrazino-benzoxazepine and -benzthiazepine derivatives, processes for their production and pharmaceutical compositions containing them | |
CS224990B1 (en) | The substituted 10-/4-/chloralkyl/piperazine/-10,11-dihydrodibenzo/b,f-thiepines and their salts | |
US4029808A (en) | Thienyl phenyl O-(aminoalkyl)-ketone oxime and furyl phenyl O-(aminoalkyl)-ketone oxime coronary vasodilators | |
US4439436A (en) | 1,3-Dioxolo(4,5-G)quinoline compounds | |
US4237135A (en) | 2-(4-Ethyl-1-piperazinyl)-4-phenylquinoline, process for preparation thereof, and composition thereof | |
US4107164A (en) | Certain pleuromulilin ester derivatives | |
FR2522000A1 (en) | NOVEL THIOPYRANNOPYRIMIDINES, PARTICULARLY USEFUL AS HYPOGLYCEMIC AGENTS, AND THEIR MANUFACTURE | |
US4032530A (en) | Certain pleuromutilins | |
US2919272A (en) | Substituted phenothiazinyl trifluoromethyl sulfones | |
CS208115B2 (en) | Method of making the imidazolylethoxyderivatives of the pyrazolo 3,4-b-pyridin-5-methanols | |
US4086244A (en) | Amidines | |
US4166126A (en) | 1-benzothiepin-4-carboxamides | |
US3989718A (en) | [1]Benzothieno[3,2-b]furans | |
US4208326A (en) | Pleuromutilin esters | |
US4226998A (en) | 1-Benzothiepin-4-carboxamides | |
CS227530B1 (en) | Esters of 8-substituted 10-(4-(hydroxyalkyl)-piperazino)10,11-dihydrodibenzo (b,f)thiepines and salts thereof | |
US4124596A (en) | Thienothienylcarbonyl-phenylalkanoic acids and derivatives thereof | |
CS223428B1 (en) | 3-Amino-M-phenyl-3-dihydrodibeuzo (b, e) thiepymes and their salts | |
US5703233A (en) | Quinilone disulfide as intermediates | |
US3518263A (en) | Basically substituted 10,5-(epoxymethano) - 10,11 - dihydro - 5h - dibenzo(a,d)cyclohepten-13-ones | |
CS197191B1 (en) | 8-chlor-10-/n up 4-alkylpiperazino/-10,11-dihydrodibenzo/b,f/thiepines having oxygen containing fuction groups in position 3 and in n-alkyl |